Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05172414 · ClinicalTrials.gov registry record
A Novel Fecal Sample Collection Method for Metagenomic Analyses
A clinical trial of Healthy, sponsored by Onegevity Health.
- Completed
- Registry status
- 6
- Enrollment target
- 1
- Study location
NCT05172414: Completed study of Healthy, sponsored by Onegevity Health.
NCT05172414 is a study of Healthy that has completed, run by Onegevity Health. The registered enrollment target is 6 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05172414, a study of Healthy, has completed, sponsored by Onegevity Health.
- COMPLETED
- Registry status
- 6 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an open-label, one-arm, one-time-point pilot assessing the intra- and inter-group variation of gut microbiome collection methods and storage conditions using metagenomic sequencing for analysis. This study recruited 6 adult volunteers collecting 12 fecal samples from one bowel movement. Subjects were given detailed instructions as to collect and store feces samples into the 4 different collection and preservation methods and return samples for metagenomic analysis.
Conditions Studied
Interventions
- OTHER No intervention
Study Locations (1)
Maryland
- Center for Integrative Medicine at the University of Maryland School of Medicine - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2020-01-02 |
| Est. Completion | 2021-08-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05172414
The ClinicalTrials.gov registry entry for NCT05172414 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (99% lower). The listed sponsor is Onegevity Health, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which No intervention is the first listed.
NCT05172414 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT05172414 about?
NCT05172414 is a clinical study titled "A Novel Fecal Sample Collection Method for Metagenomic Analyses". This is an open-label, one-arm, one-time-point pilot assessing the intra- and inter-group variation of gut microbiome collection methods and storage conditions using metagenomic sequencing for analysis. This study recruited 6 adult volunteers collecting 12 fecal samples from one bowel movement. Subj...
What is the current status of trial NCT05172414?
This trial is currently completed. The enrollment target is 6 participants. The study started on 2020-01-02. Estimated completion is 2021-08-01.
What conditions does trial NCT05172414 study?
This clinical trial studies the following conditions: Healthy.
What interventions are being tested in trial NCT05172414?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT05172414?
This trial is sponsored by Onegevity Health, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05172414 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Mapping Auricular Vagus Nerve Circuitry
RECRUITING · Early Phase 1
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
A Study of LY3867070 in Healthy Participants
RECRUITING · Phase 1
-
The Modulatory Effect of Female Sex Hormones on Spinal Neuroplasticity
RECRUITING
-
Breathing & Blood Pressure
RECRUITING
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.